by Jordana Choucair | Mar 30, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized a second COVID-19 booster shot for adults over the age of 50 as soon as four months after their initial booster dose. The Centers for Disease Control and Prevention (CDC) gave its permissive recommendation to the move,...
by Jordana Choucair | Mar 28, 2022 | Life Sciences
The Food and Drug Administration (FDA) is expected to approve additional COVID-19 booster shots for adults over the age of 50 as early as next week. Once that happens, the Centers for Disease Control and Prevention (CDC) will likely make a “permissive recommendation,”...
by Jordana Choucair | Mar 23, 2022 | Life Sciences
The American Investment Council released a report indicating that private equity firms invested nearly $70 billion in the life sciences and medical device industries last year. Deals in both sectors reached the highest amount in a decade. Life sciences deal were worth...
by Jordana Choucair | Mar 23, 2022 | Life Sciences
Moderna Inc. said it will ask regulators to authorize its COVID-19 vaccine for children between 6 months and 6 years old. The drugmaker said that two clinical trials showed the shot generated a similar immune response as among young adults, though it was less...
by Jordana Choucair | Mar 23, 2022 | Life Sciences
AstraZeneca announced it has invested roughly $33 million in Huma, a U.K.-based medical technology start-up, as part of a broader commercial partnership between the two firms. The move will enable Huma, which develops remote patient monitoring systems, to expand...
by Jordana Choucair | Mar 22, 2022 | Life Sciences
The Food and Drug Administration (FDA) is ramping up in-person inspections of drug and device manufacturing facilities that were delayed during the pandemic. The FDA said it plans to return to a “normal cadence” next month for inspections overseas, where...
Recent Comments